Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?

被引：23
|
作者：
Kumarasamy, N. [1 ,3 ]
Patel, Atul [2 ,3 ]
Pujari, Sanjay [3 ,4 ]
机构：
[1] YRG CARE Med Ctr, Voluntary Hlth Serv, Madras 600113, Tamil Nadu, India
[2] Vedant Inst Med Sci, Ahmadabad, Gujarat, India
[3] Inst Infect Dis, Pune, Maharashtra, India
[4] HIVMAI, Pune, Maharashtra, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2011年 / 134卷 / 06期
基金：
英国惠康基金;
关键词：
Antiretroviral drugs; antiretroviral therapy; ART; CD4; HIV; IRIS; viral load; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED PATIENTS; CD4 CELL COUNTS; COST-EFFECTIVENESS ANALYSIS; ZIDOVUDINE-INDUCED ANEMIA; LONG-TERM EFFICACY; LINE VIRAL LOAD; IMMUNE RECONSTITUTION; RISK-FACTORS; DRUG-RESISTANCE;
D O I：
10.4103/0971-5916.92626
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
With the rapid scale up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy - antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.
引用
收藏
页码：787 / 800
页数：14
相关论文
共 50 条
  • [31] Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop
    Chang, Ting-Tsung
    Suh, Dong Jin
    HEPATOLOGY INTERNATIONAL, 2008, 2 (Suppl 1) : S19 - S27
  • [32] What happens to pneumocystis prophylaxis use when antiretroviral therapy is widely available?
    Capocci, Santino
    Smith, Colette
    Marshall, Neal
    Tsintas, Rob
    Thomas, Fernandez
    Tyrer, Mervyn
    Johnson, Margaret
    Lipman, Marc
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [33] When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis
    Torok, Mili E.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2013, 9 (03) : 193 - 199
  • [34] When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis
    Toeroek, M. Estee
    Farrar, Jeremy J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1538 - 1540
  • [35] Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
    Franco-Paredes, Carlos
    Chastain, Daniel B.
    Rodriguez-Morales, Alfonso J.
    Marcos, Luis A.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
  • [36] Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
    Carlos Franco-Paredes
    Daniel B. Chastain
    Alfonso J. Rodriguez-Morales
    Luis A. Marcos
    Annals of Clinical Microbiology and Antimicrobials, 16
  • [37] When to Start Antiretroviral Therapy in Resource-Limited Settings
    Walensky, Rochelle P.
    Wolf, Lindsey L.
    Wood, Robin
    Fofana, Mariam O.
    Freedberg, Kenneth A.
    Martinson, Neil A.
    Paltiel, A. David
    Anglaret, Xavier
    Weinstein, Milton C.
    Losina, Elena
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (03) : 157 - W38
  • [38] When to start antiepileptic drug treatment and with what evidence?
    Marson, Anthony G.
    EPILEPSIA, 2008, 49 : 3 - 6
  • [39] BISPHOSPHONATES DILEMMA: WHEN TO START AND WHEN TO STOP OR SWITCH
    Zakraoui, L.
    Souabni, L.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S681 - S682
  • [40] GENE-THERAPY - WHEN, AND FOR WHAT
    不详
    LANCET, 1995, 345 (8952): : 739 - 740
12345